Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

When you buy through our links, we may earn a commission. Learn more› By Caira Blackwell and Joanne Chen If you’re a side-sleeper, congratulations! According to the Mayo Clinic, side sleeping ...

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...

These include the optimal dose, when to slow down or increase the dose, and any associated side effects. The quick answer is that dosing for semaglutide varies by whether you take Ozempic ...

Cost and availability: Tirzepatide is newer to the market and may be less widely available or more expensive than semaglutide. Side effects: Both medications share common side effects like nausea ...